Enviva Inc.
EVA · NYSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1,204 | $1,094 | $1,042 | $875 |
| % Growth | 10.1% | 5% | 19% | – |
| Cost of Goods Sold | $1,364 | $927 | $964 | $768 |
| Gross Profit | -$159 | $167 | $78 | $107 |
| % Margin | -13.2% | 15.2% | 7.5% | 12.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $175 | $45 |
| SG&A Expenses | $117 | $120 | $175 | $45 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $231 | $134 | $1 | $0 |
| Operating Expenses | $349 | $254 | $175 | $45 |
| Operating Income | -$508 | -$86 | -$97 | $62 |
| % Margin | -42.2% | -7.8% | -9.3% | 7.1% |
| Other Income/Exp. Net | -$178 | -$80 | -$65 | -$46 |
| Pre-Tax Income | -$686 | -$166 | -$162 | $17 |
| Tax Expense | -$0 | $2 | -$17 | $0 |
| Net Income | -$686 | -$168 | -$145 | $17 |
| % Margin | -57% | -15.4% | -13.9% | 2% |
| EPS | -9.23 | -2.54 | -2.77 | 0.33 |
| % Growth | -263.4% | 8.3% | -939.4% | – |
| EPS Diluted | -9.23 | -2.51 | -2.77 | 0.33 |
| Weighted Avg Shares Out | 74 | 66 | 52 | 52 |
| Weighted Avg Shares Out Dil | 74 | 67 | 52 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $182 | $72 | $56 | $46 |
| Depreciation & Amortization | $166 | $113 | $92 | $86 |
| EBITDA | -$338 | $19 | -$14 | $22 |
| % Margin | -28% | 1.7% | -1.3% | 2.5% |